Clearstead Advisors, LLC Abb Vie Inc. Transaction History

Clearstead Advisors, LLC

$6.31 Billion
Q3 2024

A detailed history of Clearstead Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 100,457 shares of ABBV stock, worth $18.1 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

100,457

Previous 98,456 2.03%

Holding current value

$18.1 Million

Previous $16.9 Million 17.47%

% of portfolio

0.31%

Previous 0.29%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$163.84 - $199.33 $327,843 - $398,859	2,001 Added 2.03%	100,457 $19.8 Million
Q2 2024 Aug 09, 2024	BUY	$154.79 - $180.76 $6.94 Million - $8.11 Million	44,861 Added 83.7%	98,456 $16.9 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $101,645 - $115,815	-636 Reduced 1.17%	53,595 $9.76 Million
Q4 2023 Feb 12, 2024	BUY	$137.6 - $154.97 $116,960 - $131,724	850 Added 1.59%	54,231 $8.4 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $2.08 Million - $2.4 Million	-15,547 Reduced 22.56%	53,381 $7.96 Million
Q3 2023 Nov 07, 2023	BUY	$133.59 - $154.65 $2.18 Million - $2.52 Million	16,318 Added 31.02%	68,928 $10.3 Million
Q2 2023 Aug 07, 2023	BUY	$132.51 - $164.9 $797,312 - $992,203	6,017 Added 12.91%	52,610 $7.09 Million
Q1 2023 May 09, 2023	BUY	$144.61 - $166.54 $131,739 - $151,717	911 Added 1.99%	46,593 $7.43 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $278,418 - $333,896	-2,013 Reduced 4.22%	45,682 $7.39 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $1.83 Million - $2.1 Million	-13,655 Reduced 22.26%	47,695 $6.4 Million
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $58,075 - $73,833	422 Added 0.69%	61,350 $9.4 Million
Q1 2022 May 04, 2022	BUY	$131.98 - $163.75 $98,457 - $122,157	746 Added 1.24%	60,928 $9.88 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $263,310 - $333,164	2,451 Added 4.25%	60,182 $8.15 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $369,101 - $418,985	3,469 Added 6.39%	57,731 $6.23 Million
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $60,706 - $67,630	577 Added 1.07%	54,262 $6.11 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $564,389 - $621,324	5,517 Added 11.45%	53,685 $5.81 Million
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $796,046 - $1.07 Million	9,890 Added 25.84%	48,168 $5.16 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $66,236 - $77,739	771 Added 2.06%	38,278 $3.35 Million
Q2 2020 Aug 11, 2020	BUY	$73.37 - $98.18 $794,890 - $1.06 Million	10,834 Added 40.62%	37,507 $3.68 Million
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $135,256 - $205,065	-2,097 Reduced 7.29%	26,673 $2.03 Million
Q4 2019 Feb 11, 2020	SELL	$72.13 - $90.25 $12,983 - $16,245	-180 Reduced 0.62%	28,770 $2.55 Million
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $189,506 - $227,841	-3,009 Reduced 9.42%	28,950 $2.19 Million
Q2 2019 Aug 08, 2019	BUY	$65.7 - $83.98 $37,908 - $48,456	577 Added 1.84%	31,959 $2.32 Million
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $362,789 - $426,985	-4,703 Reduced 13.03%	31,382 $2.53 Million
Q4 2018 Feb 11, 2019	SELL	$77.85 - $96.01 $70,765 - $87,273	-909 Reduced 2.46%	36,085 $3.33 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $37,786 - $42,007	425 Added 1.16%	36,994 $3.5 Million
Q2 2018 Aug 07, 2018	BUY	$89.78 - $106.23 $118,599 - $140,329	1,321 Added 3.75%	36,569 $3.39 Million
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $144,915 - $194,055	-1,575 Reduced 4.28%	35,248 $3.34 Million
Q4 2017 Feb 09, 2018	SELL	$89.56 - $98.21 $368,360 - $403,937	-4,113 Reduced 10.05%	36,823 $3.56 Million
Q3 2017 Nov 09, 2017	BUY	$69.85 - $89.22 $2.86 Million - $3.65 Million	40,936	40,936 $3.64 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.

Account

Clearstead Advisors, LLC Abb Vie Inc. Transaction History